Targeting programmed death ligand 1 for anticancer therapy using computational drug repurposing and molecular simulations

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Scientific Reports (Nature Publisher Group) vol. 15, no. 1 (2025), p. 28742-28754
1. Verfasser:	Khan, Mohd Shahnawaz
Weitere Verfasser:	Shamsi, Anas, Shahwan, Moyad, Dinislam, Khuzin, Yadav, Dharmendra Kumar
Veröffentlicht:	Nature Publishing Group
Schlagworte:	Food & Drug Administration > FDA Cancer PD-L1 protein Binders Bioinformatics Therapeutic targets Binding sites Biological products Drug development Computer applications Molecular dynamics Efficiency Proteins Simulation Principal components analysis FDA approval Immune checkpoint Antineoplastic drugs Pharmacokinetics Ligands Immunosuppressive agents Cancer therapies Environmental
Online-Zugang:	Citation/Abstract Full Text Full Text - PDF
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!

Schreiben Sie den ersten Kommentar!